Cogent Biosciences filed an offering with the SEC, with Leerink partners as the joint book-running manager and Broadridge handling prospectus info.
3 reports, 1 independent
Updated Jul 11
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cogent Biosciences filed an offering with the SEC, with Leerink partners as the joint book-running manager and Broadridge handling prospectus info.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Cogent Biosciences (United States)
company in Waltham, United States
Nothing else this week.
-
Leerink partners
U.S. investment bank
-
Broadridge Financial Solutions
American corporate services company
Nothing else this week.
Related events
- Leerink Partners is a joint bookrunning manager for an offering by Retension Pharmaceuticals, Inc., with the prospectus available from Boston, MA.
- Broadridge Financial Solutions and TaskUs are being compared as industrial companies.
- Kazia Therapeutics Limited is seeking joint bookrunning management and co-management for a proposed offering, with Leerink partners and Needham & Company involved.
- Leerink Partners is acting as a placement agent for First Tracks Biotherapeutics.
Coverage
Newest first; wire copies grouped- GlobeNewswireCogent Biosciences Announces Closing of Upsized Public Offering of Shares of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares WALTHAM, Mass. and BOULDER, Colo., Ju
- Unknown outlet
- Unknown outlet